Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Oncol. Jan 24, 2022; 13(1): 49-61
Published online Jan 24, 2022. doi: 10.5306/wjco.v13.i1.49
Table 3 Distribution of cancers based on genetic diagnosis by comorbid inflammatory condition status
CID present
CID non present
CRC
LS specific1
All other
CRC
LS specific
All other
MLH12 (40.0)2 (40.0)1 (20.0)2 (20.0)2 (20.0)0 (0)
MSH22 (66.7)0 (0)1 (33.3)2 (28.6)4 (57.1)1 (14.3)
MSH60 (0)0 (0)0 (0)2 (50.0)1 (25.0)0 (0)
PMS22 (50.0)0 (0)1 (25.0)0 (0)2 (25.0)0 (0)
No MMRPV3 (42.9)1 (14.3)1 (14.3)6 (42.9)1 (7.1)0 (0)